Diabetes, Vol 40, Issue 12 1725-1730, Copyright © 1991 by American Diabetes Association

ARTICLES

Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes

DG Dills, SE Moss, R Klein and BE Klein
Department of Medicine, University of Wisconsin School of Medicine, Madison.

Insulinlike growth factor I (IGF-I) has been suggested to play a role in the pathogenesis of proliferative diabetic retinopathy (PDR). We determined IGF-I levels in subjects in a large population-based study of 928 people with diabetes diagnosed at 30 yr of age or older. PDR was found in 15.7% of the insulin-using group (n = 517) and in 2.8% of those not using insulin (n = 397). The mean serum level of IGF-I was 208 micrograms/L in individuals using insulin and 222 micrograms/L in those not using insulin, both significantly lower than in a nondiabetic comparison group (278 micrograms/L, P less than 0.0001). Logistic regression analysis was used to examine the relationship between IGF-I and PDR while controlling for other factors associated with the presence of PDR. After controlling for duration of diabetes, glycosylated hemoglobin, systolic blood pressure, presence of proteinuria, and age at diagnosis, higher levels of IGF-I were significantly associated with an increased frequency of PDR (P = 0.025) in the group using insulin. In individuals not using insulin, higher levels of IGF-I were associated with an increased frequency of PDR or moderate non-PDR (P = 0.08). These data suggest that higher IGF-I levels may be a risk factor for the development of severe retinopathy in people with diabetes diagnosed at 30 yr of age or older.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. C. Miller, B. E. Capps, R. R. Sanghani, D. R. Clemmons, and L. A. Maile Regulation of IGF-I Signaling in Retinal Endothelial Cells by Hyperglycemia Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3878 - 3887. [Abstract] [Full Text] [PDF]

				P. B. Bergman, C. J. Moravski, S. R. Edmondson, V. C. Russo, L. A. Bach, J. L. Wilkinson-Berka, and G. A. Werther Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2708 - 2715. [Abstract] [Full Text] [PDF]

				L. C. Shaw, A. Afzal, A. S. Lewin, A. M. Timmers, P. E. Spoerri, and M. B. Grant Decreased Expression of the Insulin-like Growth Factor 1 Receptor by Ribozyme Cleavage Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4105 - 4113. [Abstract] [Full Text] [PDF]

				P. E. Spoerri, S. Caballero, S. H. Wilson, L. C. Shaw, and M. B. Grant Expression of IGFBP-3 by Human Retinal Endothelial Cell Cultures: IGFBP-3 Involvement in Growth Inhibition and Apoptosis Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 365 - 369. [Abstract] [Full Text] [PDF]

				N. INOKUCHI, T. IKEDA, F. YASUDA, S. SHIRAI, and Y. UCHIHORI Severe proliferative diabetic retinopathy associated with acromegaly Br. J. Ophthalmol., May 1, 1999; 83(5): 628c - 628. [Full Text]

				M. Boulton, D. Foreman, G. Williams, and D. McLeod VEGF localisation in diabetic retinopathy Br. J. Ophthalmol., May 1, 1998; 82(5): 561 - 568. [Abstract] [Full Text]

				M. Nishimura, K. Nakano, M. Ushiyama, A. Nanbu, K. Ohtsuka, H. Takahashi, and M. Yoshimura Increased Serum Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 195 - 198. [Abstract] [Full Text]

				R. S. Warren, H. Yuan, M. R. Matli, N. Ferrara, and D. B. Donner Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1in Colorectal Carcinoma J. Biol. Chem., November 15, 1996; 271(46): 29483 - 29488. [Abstract] [Full Text] [PDF]